DESTINY PHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.25 GBX | -2.99% |
|
-23.53% | -76.79% |
| Apr. 25 | Norcros sells Johnson Tiles UK; Trifast trading well | AN |
| Apr. 25 | AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract | AN |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 27.01 | 18.86 | 40.97 | 62.87 | 39.22 | 15.49 | 15.49 | - |
| Enterprise Value (EV) 1 | 14.95 | 11.36 | 31.23 | 58.22 | 34.32 | 66.69 | 13.79 | 22.49 |
| P/E ratio | -5.21 x | -4.02 x | -5.71 x | -11.8 x | -5.75 x | -11.3 x | -2.62 x | -1.91 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | 61.7 x | - | 629 x | - | 80.2 x | 19.4 x | - |
| EV / Revenue | - | 37.1 x | - | 582 x | - | 80.2 x | 17.2 x | - |
| EV / EBITDA | -2.46 x | - | -4.78 x | -9.28 x | -4.78 x | -11.2 x | -2.32 x | - |
| EV / FCF | -3.15 x | - | -5.68 x | -11.4 x | -5.82 x | -1.81 x | -2.39 x | - |
| FCF Yield | -31.7% | - | -17.6% | -8.8% | -17.2% | -55.4% | -41.8% | - |
| Price to Book | - | - | 3.29 x | 8.37 x | 5.14 x | 1.93 x | 5.38 x | - |
| Nbr of stocks (in thousands) | 43,563 | 43,865 | 59,817 | 59,872 | 73,307 | 95,312 | 95,312 | - |
| Reference price 2 | 0.6200 | 0.4300 | 0.6850 | 1.050 | 0.5350 | 0.1625 | 0.1625 | 0.1625 |
| Announcement Date | 4/9/19 | 4/29/20 | 4/14/21 | 4/12/22 | 4/13/23 | 4/25/24 | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 0.3059 | - | 0.1 | - | 0.8316 | 0.8 | - |
| EBITDA 1 | -6.074 | - | -6.536 | -6.274 | -7.178 | -5.971 | -5.951 | - |
| EBIT 1 | -6.084 | -5.585 | -6.553 | -6.287 | -7.776 | -6.736 | -6.065 | -8 |
| Operating Margin | - | -1,825.62% | - | -6,286.95% | - | -810.05% | -758.18% | - |
| Earnings before Tax (EBT) 1 | -6.008 | -5.521 | -6.481 | -6.271 | -7.712 | -6.446 | -6.387 | - |
| Net income 1 | -5.167 | -4.708 | -5.411 | -5.339 | -6.504 | -5.657 | -5.618 | -8 |
| Net margin | - | -1,539.02% | - | -5,339.48% | - | -680.3% | -702.31% | - |
| EPS 2 | -0.1190 | -0.1070 | -0.1200 | -0.0890 | -0.0930 | -0.0620 | -0.0620 | -0.0850 |
| Free Cash Flow 1 | -4.739 | - | -5.494 | -5.121 | -5.893 | -4.662 | -5.768 | - |
| FCF margin | - | - | - | -5,120.69% | - | -477.07% | -721.03% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 4/9/19 | 4/29/20 | 4/14/21 | 4/12/22 | 4/13/23 | 4/25/24 | - | - |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | 7 |
| Net Cash position 1 | 12.1 | 7.5 | 9.74 | 4.65 | 4.9 | 7.07 | 1.7 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -4.74 | - | -5.49 | -5.12 | -5.89 | -4.66 | -5.77 | - |
| ROE (net income / shareholders' equity) | -35.7% | - | -53.6% | -53.5% | -85.9% | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | - | - | 0.2100 | 0.1300 | 0.1000 | 0.0800 | 0.0300 | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 0.02 | 0.02 | 0 | 0.03 | 0 | 0.65 | 0 | - |
| Capex / Sales | - | 6.85% | - | 30.26% | - | 66.52% | 0.12% | - |
| Announcement Date | 4/9/19 | 4/29/20 | 4/14/21 | 4/12/22 | 4/13/23 | 4/25/24 | - | - |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1625
GBP
Average target price
2.083
GBP
Spread / Average Target
+1,182.05%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -76.79% | 19.29M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- DEST Stock
- Financials Destiny Pharma plc
